Type-3 Metabotropic Glutamate Receptors and Parkinson's Disease: Preclinical Studies and Human Genetics

被引：0
|
作者：
Alborghetti, M. [1 ]
Di Menna, L. [1 ]
Traficante, A. [1 ]
Bruno, V. [1 ]
Monn, J. [1 ]
Nicoletti, F. [1 ]
Pontieri, F. E. [1 ]
Bianchini, E. [1 ]
Spalletta, G. [1 ]
Borro, M. [1 ]
Simmaco, M. [1 ]
Battaglia, G. [1 ]
机构：
[1] Neurosci Mental Hlth & Sensory Organs NESMOS, Rome, Italy
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
523
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [21] Role of metabotropic glutamate receptors in striatal cholinergic transmission: Implications for Parkinson's disease
    Bonsi, P
    Cuomo, D
    Calabresi, P
    Bernardi, G
    MOVEMENT DISORDERS, 2004, 19 : S47 - S47
  • [22] NMDA-metabotropic glutamate receptors interaction in a rat model of Parkinson's disease
    Breysse, N
    Amalric, M
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S75 - S75
  • [23] The role of metabotropic glutamate receptors in Alzheimer's disease
    Lee, H
    Zhu, XW
    O'Neill, MJ
    Webber, K
    Casadesus, G
    Marlatt, M
    Raina, AK
    Perry, G
    Smith, MA
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2004, 64 (01) : 89 - 98
  • [24] Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease
    Duty, Susan
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (02) : 271 - 287
  • [25] Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease
    Dekundy, A
    Pietraszek, M
    Schaefer, D
    Cenci, MA
    Danysz, W
    BRAIN RESEARCH BULLETIN, 2006, 69 (03) : 318 - 326
  • [26] Genetic variants of the type-3 metabotropic glutamate receptor gene associated with human spatial localization ability
    Li, Junlin
    Yu, Yan
    Zhao, Junhong
    Zhang, Jing
    Wang, Yan
    Ding, Kefan
    Gao, Xiaocai
    Zhang, Kejin
    GENE REPORTS, 2021, 23
  • [27] The Role of Metabotropic Glutamate Receptors Type 3 and 5 in Parkinson's disease (PD): Analysis of grm3 and grm5 Gene Variants
    Alborghetti, M.
    Bianchini, E.
    Rinaldi, D.
    De Bartolo, I.
    Di Menna, L.
    Battaglia, G.
    Bruno, V.
    Esposito, T.
    Borro, M.
    Simmaco, M.
    Pontieri, F.
    Berardelli, A.
    Nicoletti, F.
    MOVEMENT DISORDERS, 2024, 39 : S782 - S782
  • [28] Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson's Disease: Bridging Molecular Studies and Clinical Trials
    Vallano, A.
    Fernandez-Duenas, V.
    Garcia-Negredo, G.
    Quijada, M. A.
    Simon, C. P.
    Cuffi, M. L.
    Carbonell, L.
    Sanchez, S.
    Arnau, J. M.
    Ciruela, F.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (08) : 1128 - 1142
  • [29] Effects of the blockade of subtype 1 metabotropic glutamate receptors (mGIuRs) in models of Parkinson's disease in the rat
    Ossowska, K
    Wardas, J
    Konieczny, J
    Pietraszek, M
    Zapala, M
    Wolfarth, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S370 - S370
  • [30] The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: Implications for the therapy of Parkinson's disease
    Wardas, J
    Pietraszek, M
    Wolfarth, S
    Ossowska, K
    NEUROSCIENCE, 2003, 122 (03) : 747 - 756
12345